Effects of dapagliflozin compared with glimepiride on body composition in Asian patients with type 2 diabetes inadequately controlled with metformin: The BEYOND study
Diabetes, Obesity and Metabolism · 2023
DOI: 10.1111/dom.15164 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Diabetes, Obesity and Metabolism, 2023. Verfasst von Hyeong Kyu Park und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology and Metabolism, Department of Internal Medicine, Soonchunhyang University Hospital, Soonchunhyang University College of Med…. Hauptthemen laut MEDLINE: Metformin, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: AstraZeneca Korea.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Aims To evaluate the effect of dapagliflozin on body composition such as total body fat (BF) mass, abdominal visceral adipose tissue (VAT), and subcutaneous adipose tissue (SAT) areas compared with glimepiride in Korean patients with type 2 diabetes. Materials and Methods This was a 52‐week, multicentre, randomized, parallel‐group, open‐label, Phase IV (NCT02564926) study. Patients with inadequate glycaemic control (glycated haemoglobin ≥7.0% and
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Endocrinology and Metabolism, Department of Internal Medicine, Soonchunhyang University Hospital, Soonchunhyang University College of Medicine, Seoul, Korea.
- Department of Internal Medicine, Dongguk University Ilsan Hospital, Dongguk University School of Medicine, Goyang, Korea.
- Department of Internal Medicine, Eulji General Hospital, Eulji University School of Medicine, Seoul, Korea.
- Division of Endocrinology and Metabolism, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea.
- Division of Endocrinology and Metabolism, Department of Internal Medicine, Kyung Hee University Hospital at Gangdong, Kyung Hee University School of Medicine, Seoul, Korea.
- Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
ORCID-Profile: Hyeong Kyu Park, Kyoung-Ah Kim, Nan-Hee Kim, Choon Hee Chung, Kwan Woo Lee
Förderung
- AstraZeneca Korea
Zitieren
APA
Park, H. K., Kim, K. A., Min, K. W., Sohn, T. S., Jeong, I. K., Ahn, C. W., Kim, N. H., Park, I. B., Cho, H. C., Chung, C. H., Choi, S. H., Park, K. S., Yang, S. O., & Lee, K. W. (2023). Effects of dapagliflozin compared with glimepiride on body composition in Asian patients with type 2 diabetes inadequately controlled with metformin: The BEYOND study. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.15164
Vancouver
Park HK, Kim KA, Min KW, Sohn TS, Jeong IK, Ahn CW, et al. Effects of dapagliflozin compared with glimepiride on body composition in Asian patients with type 2 diabetes inadequately controlled with metformin: The BEYOND study. Diabetes, Obesity and Metabolism. 2023. doi:10.1111/dom.15164
BibTeX
@article{Park2023,
author = {Park, Hyeong Kyu and Kim, Kyoung-Ah and Min, Kyung-Wan and Sohn, Tae-Seo and Jeong, In Kyung and Ahn, Chul Woo and Kim, Nan-Hee and Park, Ie Byung and Cho, Ho Chan and Chung, Choon Hee and Choi, Sung Hee and Park, Kang Seo and Yang, Seoung-Oh and Lee, Kwan Woo},
title = {Effects of dapagliflozin compared with glimepiride on body composition in Asian patients with type 2 diabetes inadequately controlled with metformin: The BEYOND study},
journal = {Diabetes, Obesity and Metabolism},
year = {2023},
doi = {10.1111/dom.15164}
}
EUVIMED